These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 953996)

  • 21. [Immunodiagnostic aspects of breast cancer. The phenomenon of leukocyte adherence inhibition].
    Fritze D; Fritze J; Kaufmann M; Drings P
    Minerva Med; 1978 Nov; 69(58):3963-7. PubMed ID: 740287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunity to tumor-associated antigens in vasectomized men.
    Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
    J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
    Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
    Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukocyte adherence inhibition responses obtained with various tumor extracts in breast cancer patients.
    Kovarík J; Lauerová L; Feit J; Ninger E; Munzarová M; Zemanová D; Hlávková J
    Cancer Detect Prev; 1983; 6(1-2):215-9. PubMed ID: 6349799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukocyte migration inhibition response to various antigen preparations of autologous and homologous breast cancer in patients with primary breast cancer.
    Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
    J Natl Cancer Inst; 1979 Nov; 63(5):1161-9. PubMed ID: 91696
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunological monitoring in lung cancer: use of the leukocyte migration inhibition assay.
    Abai AM; Fekete B
    Haematologia (Budap); 1982; 15(1):111-25. PubMed ID: 6749608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indirect macrophage migration inhibition response to 3-M KCl extract of gastric carcinoma.
    Akiyoshi T; Koba F; Kawaguchi M; Miyazaki S; Tsuji H
    J Natl Cancer Inst; 1982 Aug; 69(2):345-7. PubMed ID: 6955541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
    Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
    Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of pre-existent immunity in patients with primary breast cancer: molecular and cellular assays to quantify antigen-specific T lymphocytes in peripheral blood mononuclear cells.
    Rentzsch C; Kayser S; Stumm S; Watermann I; Walter S; Stevanoviç S; Wallwiener D; Gückel B
    Clin Cancer Res; 2003 Oct; 9(12):4376-86. PubMed ID: 14555509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macrophage migration inhibition factor test in breast tumors.
    Gutman H; Kott I; Rabinerson D; Reiss R
    Isr J Med Sci; 1986 Nov; 22(11):812-6. PubMed ID: 3793437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The LMI test in colon, breast and lung cancer long survivors.
    Fazio M; Calabrese F; Coluccia C; Giacomasso S; Casadio C; Mancuso M; Negri L; Mastromatteo V
    Panminerva Med; 1992; 34(2):60-4. PubMed ID: 1408329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Improvement of specificity and reactivity of the leukocyte migration test for the diagnosis and follow-up care in stomach cancer].
    Schulz U; Zoeller M; Matzku S
    Chir Forum Exp Klin Forsch; 1977 Apr; ():63-8. PubMed ID: 618315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of a breast tissue-associated antigen by antiserum to Raji cell-bound circulating immune complexes of human breast cancer.
    Koestler TP; Papsidero LD; Nemoto T; Chu TM
    Cancer Res; 1981 Jul; 41(7):2900-7. PubMed ID: 7018673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukocyte migration inhibition response to breast cancer antigens and to mouse mammary tumor virus in women with primary breast cancer.
    Fukuda M; Wanebo HJ; Tsuei L; Sarkar NH
    Surg Forum; 1978; 29():167-9. PubMed ID: 233830
    [No Abstract]   [Full Text] [Related]  

  • 37. An analysis of age and family history on outcome after breast-conservation treatment: the University of Pennsylvania experience.
    Haas JA; Schultz DJ; Peterson ME; Solin LJ
    Cancer J Sci Am; 1998; 4(5):308-15. PubMed ID: 9815295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Possible prognostic value of arterial hypertension in postmenopausal women with breast cancer in complete clinical remission. Pilot study].
    López-Sáez JB; Quintela Senra D; Senra Varela A
    An Med Interna; 2001 Mar; 18(3):132-5. PubMed ID: 11594177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tests of cell mediated immunity in patients with early breast cancer. I. Response to DNCB at time of mastectomy.
    Davies CJ; Meredith ID; Robins RA; Blamey RW; Baldwin RW
    Clin Oncol; 1978 Sep; 4(3):227-34. PubMed ID: 750125
    [No Abstract]   [Full Text] [Related]  

  • 40. Problems in the clinical use of the microcytotoxicity assay for measuring cell-mediated immunity to tumor cells.
    Heppner G; Henry E; Stolbach L; Cummings F; McDonough E; Calabresi P
    Cancer Res; 1975 Aug; 35(8):1931-7. PubMed ID: 1149017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.